Stock listing

GOSS Stock Price, News, Filings & Events — Gossamer Bio, Inc.

Selected listing: GOSS · BOATS · USD · US

This page tracks Gossamer Bio, Inc.'s GOSS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GOSS:BOATS. GOSS:BOATS is the stock-level entry point for investors researching Gossamer Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Gossamer Bio, Inc. is a public company traded under the ticker GOSS in the American market. The company has a market capitalization of approximately $66.5 million. Gossamer Bio focuses on developing innovative therapies to address unmet medical needs.

GOSS:BOATSUSDUSUpdated August 14, 2026
Gossamer Bio, Inc. logo
Ticker
GOSS:BOATS
Asset type
Stock
Market cap
$75.4M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Gossamer Bio, Inc. GOSS:BOATS stock context

This page tracks Gossamer Bio, Inc.'s GOSS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GOSS:BOATS. GOSS:BOATS is the stock-level entry point for investors researching Gossamer Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Gossamer Bio, Inc. is a public company traded under the ticker GOSS in the American market. The company has a market capitalization of approximately $66.5 million. Gossamer Bio focuses on developing innovative therapies to address unmet medical needs.

Research Gossamer Bio, Inc.

Alternate listings